• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Infect Genet Evol . SARS-CoV-2 introduction and lineage dynamics across three epidemic peaks in Southern Brazil: Massive spread of P.1

tetano

Editor, Senior Moderator
Infect Genet Evol


. 2021 Nov 16;96:105144.
doi: 10.1016/j.meegid.2021.105144. Online ahead of print.
SARS-CoV-2 introduction and lineage dynamics across three epidemic peaks in Southern Brazil: Massive spread of P.1


Ana Paula Muterle Varela[SUP] 1 [/SUP], Janira Prichula[SUP] 1 [/SUP], Fabiana Quoos Mayer[SUP] 2 [/SUP], Richard Steiner Salvato[SUP] 3 [/SUP], Fernando Hayashi Sant'Anna[SUP] 4 [/SUP], Tatiana Schäffer Gregianini[SUP] 3 [/SUP], Letícia Garay Martins[SUP] 5 [/SUP], Adriana Seixas[SUP] 1 [/SUP], Ana B G Veiga[SUP] 6 [/SUP]



Affiliations
Free PMC article

Abstract

Genomic surveillance of SARS-CoV-2 is paramount for understanding viral dynamics, contributing to disease control. This study analyzed SARS-CoV-2 genomic diversity in Rio Grande do Sul (RS), Brazil, including the first reported case in each Regional Health Coordination and cases from three epidemic peaks. Ninety SARS-CoV-2 genomes from RS were sequenced and analyzed against SARS-CoV-2 datasets available in GISAID for phylogenetic inference and mutation analysis. Among the first reported cases, we found the following lineages: B.1 (33.3%), B.1.1.28 (26.7%), B.1.1 (13.3%), B.1.1.33 (10.0%), and A (6.7%), evidencing SARS-CoV-2 introduction by both international origin and community-driven transmission. We found predominance of B.1.1.33 (50.0%) and B.1.1.28 (35.0%) during the first epidemic peak (July-August 2020), emergence of P.2 (55.6%) in the second peak (November-December 2020), and massive spread of P.1 and related sequences (78.4%), such as P.1-like-II, P.1.1 and P.1.2 in the third peak (February-April, 2021). Eighteen novel mutation combinations were found among P.1 genomes, and 22 different spike mutations and/or deletions among P.1 and related sequences. This study shows the dispersion of SARS-CoV-2 lineages in Southern Brazil and describes SARS-CoV-2 diversity during three epidemic peaks, highlighting the spread of P.1 and the high genetic diversity of currently circulating lineages. Genomic monitoring of SARS-CoV-2 is essential to guide health authorities' decisions to control COVID-19 in Brazil.

Keywords: Brazil; Epidemic peaks; Genomic diversity; P.1 lineage; Severe acute respiratory syndrome coronavirus 2.
 
Back
Top Bottom